BDC Capital provides mezz funding to venture-backed Nicoya

BDC Capital has provided undisclosed mezzanine financing to Nicoya Lifesciences Inc, a Kitchener, Ontario-based nanotechnology company. The funding is part of a $7.7 million investment in Nicoya that is also backed by FedDev Ontario. BDC invested through its Growth & Transition Capital group. The funds raised will allow Nicoya to develop and market a new version of its flagship product, OpenSPR, a biosensor platform that supports biotechnology and pharmaceutical research applications, and meet demand. Last year, Nicoya closed a $2 million financing led by Ripple Ventures and Golden Triangle Angel Network. BDC also invested in the round.

CanadaNorth AmericaBriefs